APA (7th ed.) Citation

Flume, P., VanDevanter, D. R., Morgan, E., Dudley, M. N., Loutit, J. S., Bell, S. C., . . . Elborn, J. S. (2016). A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients. Elsevier.

Chicago Style (17th ed.) Citation

Flume, Patrick, et al. A Phase 3, Multi-center, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients. Elsevier, 2016.

MLA (9th ed.) Citation

Flume, Patrick, et al. A Phase 3, Multi-center, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients. Elsevier, 2016.